Careers  |  Sign In  |  Register  |   Twitter

Latest in Pharmacists

Reuters Health • The Doctor's Channel Daily Newscast

Hormone therapy linked to ovarian cancer

NEW YORK (Reuters Health) – New research suggests that regardless of how hormone therapy is given, it increases the risk of ovarian cancer. “Our study suggests an increased risk of ovarian cancer with both estrogen therapy and combined hormone therapy, with little influence of different regimens,...

Reuters Health • The Doctor's Channel Daily Newscast

Hormone therapy still risky when started soon after menopause

NEW YORK (Reuters Health) – A further analysis of data from the Women’s Health Initiative (WHI) trials indicates that the risks of hormone therapy still generally outweigh the benefits, even when initiated soon after menopause. WHI trials examining the use of conjugated equine estrogens (CEE) with or...

Reuters Health • The Doctor's Channel Daily Newscast

Single-tablet daily ART regimen maintains high rate of HIV-1 suppression

NEW YORK (Reuters Health) – In a prospective, randomized trial, a single daily tablet containing efavirenz, emtricitabine, and tenofovir (Atripla; Bristol Myers Squibb & Gilead Sciences LLC) maintained viral suppression in HIV-1 infected patients as well as the standard multiple-pill regimen. The...